PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-85.48%
Cash & equivalents declining signals potential liquidity drain. Benjamin Graham would investigate if this is from strategic investments or operational shortfalls.
No Data
No Data available this quarter, please select a different quarter.
-85.48%
Declining total liquid assets may signal capital redeployment or liquidity concerns. Howard Marks would investigate the underlying causes.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2826.88%
Total current assets yoy growth ≥ 20% – robust short-term liquidity expansion. Warren Buffett would confirm if composition (cash vs. receivables) is healthy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2826.88%
Total assets up ≥ 20% yoy – large expansion. Benjamin Graham checks if acquisitions or reinvestments are wisely priced.
-6.18%
Declining payables indicates faster supplier payments but reduces free financing. Howard Marks would verify liquidity remains adequate.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
10.20%
Up to 15% yoy – moderate increase. Howard Marks watches if working capital covers this growth.
3.22%
Up to 5% yoy – small increase. Howard Marks questions if cash flow comfortably covers new interest.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3.22%
Up to 5% yoy – small increase. Howard Marks questions if the firm's cash flow can handle incremental obligations.
No Data
No Data available this quarter, please select a different quarter.
5.38%
Up to 10% yoy – modest increase. Howard Marks questions if incremental liabilities are productive.
No Data
No Data available this quarter, please select a different quarter.
10.06%
10-20% yoy – healthy expansion in retained earnings. Warren Buffett sees it as fueling future growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
26.94%
Equity growth ≥ 10% yoy – a strengthening net worth. Warren Buffett checks if the ROE is healthy.
2826.88%
≥ 12% yoy – significant balance sheet expansion. Benjamin Graham checks if the new capital is productive.
No Data
No Data available this quarter, please select a different quarter.
3.22%
Up to 5% yoy – small increase. Howard Marks questions if coverage ratios remain comfortable.
4.70%
Up to 5% yoy – small net debt increase. Howard Marks questions if operating cash flow covers the incremental borrowing.